HEADER IMMUNE SYSTEM 16-APR-22 7XJF TITLE CRYSTAL STRUCTURE OF 6MW3211 FAB IN COMPLEX WITH CD47 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAVY CHAIN OF 6MW3211 FAB; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN OF 6MW3211 FAB; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: LEUKOCYTE SURFACE ANTIGEN CD47; COMPND 11 CHAIN: C; COMPND 12 SYNONYM: ANTIGENIC SURFACE DETERMINANT PROTEIN OA3,INTEGRIN- COMPND 13 ASSOCIATED PROTEIN,IAP,PROTEIN MER6; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 GENE: CD47, MER6; SOURCE 22 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 23 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 25 EXPRESSION_SYSTEM_CELL: CHO KEYWDS CD47, ANTIBODY, FAB, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.WANG,R.WANG,S.JIAO,S.WANG,J.ZHANG,M.ZHANG,M.WANG REVDAT 2 29-NOV-23 7XJF 1 REMARK REVDAT 1 31-MAY-23 7XJF 0 JRNL AUTH R.WANG,C.ZHANG,Y.CAO,J.WANG,S.JIAO,J.ZHANG,M.WANG,P.TANG, JRNL AUTH 2 Z.OUYANG,W.LIANG,Y.MAO,A.WANG,G.LI,J.ZHANG,M.WANG,S.WANG, JRNL AUTH 3 X.GUI JRNL TITL BLOCKADE OF DUAL IMMUNE CHECKPOINT INHIBITORY SIGNALS WITH A JRNL TITL 2 CD47/PD-L1 BISPECIFIC ANTIBODY FOR CANCER TREATMENT. JRNL REF THERANOSTICS V. 13 148 2023 JRNL REFN ISSN 1838-7640 JRNL PMID 36593962 JRNL DOI 10.7150/THNO.79367 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 31543 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1702 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.8300 - 5.9500 0.99 2639 153 0.1934 0.2184 REMARK 3 2 5.9500 - 4.7200 1.00 2535 137 0.1436 0.1815 REMARK 3 3 4.7200 - 4.1300 1.00 2506 158 0.1278 0.1514 REMARK 3 4 4.1300 - 3.7500 1.00 2518 116 0.1469 0.1960 REMARK 3 5 3.7500 - 3.4800 1.00 2458 158 0.1577 0.2009 REMARK 3 6 3.4800 - 3.2800 1.00 2495 130 0.1861 0.2462 REMARK 3 7 3.2800 - 3.1100 1.00 2456 132 0.2037 0.2557 REMARK 3 8 3.1100 - 2.9800 1.00 2453 142 0.2248 0.2837 REMARK 3 9 2.9800 - 2.8600 1.00 2426 145 0.2377 0.3135 REMARK 3 10 2.8600 - 2.7600 1.00 2447 145 0.2627 0.3229 REMARK 3 11 2.7600 - 2.6800 1.00 2439 145 0.2858 0.3591 REMARK 3 12 2.6800 - 2.6000 1.00 2469 141 0.3048 0.3432 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.340 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7XJF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-APR-22. REMARK 100 THE DEPOSITION ID IS D_1300028960. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-NOV-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NFPSS REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31874 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9.800 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.40 REMARK 200 R MERGE FOR SHELL (I) : 1.01000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5TZU, 6JJP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 M DL-MALIC ACID, PH 5.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.41500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.66000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.24000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.66000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.41500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.24000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 227 REMARK 465 CYS B 214 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 16 -173.02 -68.98 REMARK 500 SER A 143 98.20 -164.83 REMARK 500 ASP A 155 74.15 64.31 REMARK 500 THR B 51 -40.85 68.86 REMARK 500 ALA B 84 179.50 175.85 REMARK 500 ASN B 138 70.87 53.60 REMARK 500 LYS B 190 -56.62 -120.19 REMARK 500 ASP C 17 -72.77 -84.54 REMARK 500 ASN C 27 45.73 -86.03 REMARK 500 LEU C 101 -117.49 52.36 REMARK 500 REMARK 500 REMARK: NULL DBREF 7XJF A 1 227 PDB 7XJF 7XJF 1 227 DBREF 7XJF B 1 214 PDB 7XJF 7XJF 1 214 DBREF 7XJF C 1 116 UNP Q08722 CD47_HUMAN 19 134 SEQADV 7XJF GLY C 15 UNP Q08722 CYS 33 ENGINEERED MUTATION SEQRES 1 A 227 GLU VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 A 227 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 A 227 TYR LYS PHE THR ASN TYR VAL MET SER TRP VAL ARG GLN SEQRES 4 A 227 ALA PRO GLY GLN ARG LEU GLU TRP MET GLY TYR ILE ASN SEQRES 5 A 227 PRO TYR ASN ASP ALA ILE LYS TYR ASN GLU LYS PHE THR SEQRES 6 A 227 GLY ARG VAL THR ILE THR ARG ASP THR SER ALA SER THR SEQRES 7 A 227 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 A 227 ALA VAL TYR TYR CYS ALA ARG GLU GLY ASP PHE TYR ALA SEQRES 9 A 227 ASN TYR GLY ARG LEU GLY PHE ALA TYR TRP GLY GLN GLY SEQRES 10 A 227 THR LEU VAL THR VAL SER SER ALA SER THR LYS GLY PRO SEQRES 11 A 227 SER VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER SEQRES 12 A 227 GLY GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR SEQRES 13 A 227 PHE PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA SEQRES 14 A 227 LEU THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SEQRES 15 A 227 SER SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL SEQRES 16 A 227 PRO SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN SEQRES 17 A 227 VAL ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS SEQRES 18 A 227 VAL GLU PRO LYS SER CYS SEQRES 1 B 214 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 B 214 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 B 214 GLN ASP ILE SER ASN TYR LEU ASN TRP TYR GLN GLN LYS SEQRES 4 B 214 PRO GLY LYS ALA PRO LYS LEU LEU LEU TYR TYR THR SER SEQRES 5 B 214 ARG LEU HIS SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 B 214 GLY SER GLY THR ASP TYR THR LEU THR ILE SER SER LEU SEQRES 7 B 214 GLN PRO GLU ASP PHE ALA THR TYR PHE CYS GLN GLN GLY SEQRES 8 B 214 ALA GLY PHE PRO TYR THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 B 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 B 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 B 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 B 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 B 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 B 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 B 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 B 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 B 214 PHE ASN ARG GLY GLU CYS SEQRES 1 C 116 GLN LEU LEU PHE ASN LYS THR LYS SER VAL GLU PHE THR SEQRES 2 C 116 PHE GLY ASN ASP THR VAL VAL ILE PRO CYS PHE VAL THR SEQRES 3 C 116 ASN MET GLU ALA GLN ASN THR THR GLU VAL TYR VAL LYS SEQRES 4 C 116 TRP LYS PHE LYS GLY ARG ASP ILE TYR THR PHE ASP GLY SEQRES 5 C 116 ALA LEU ASN LYS SER THR VAL PRO THR ASP PHE SER SER SEQRES 6 C 116 ALA LYS ILE GLU VAL SER GLN LEU LEU LYS GLY ASP ALA SEQRES 7 C 116 SER LEU LYS MET ASP LYS SER ASP ALA VAL SER HIS THR SEQRES 8 C 116 GLY ASN TYR THR CYS GLU VAL THR GLU LEU THR ARG GLU SEQRES 9 C 116 GLY GLU THR ILE ILE GLU LEU LYS TYR ARG VAL VAL HET NAG D 1 14 HET NAG D 2 14 HET FUC D 3 10 HET NAG E 1 14 HET FUC E 2 10 HET NAG F 1 14 HET FUC F 2 10 HET CL A 301 1 HET CL B 301 1 HET NAG C 201 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 4 NAG 5(C8 H15 N O6) FORMUL 4 FUC 3(C6 H12 O5) FORMUL 7 CL 2(CL 1-) FORMUL 10 HOH *252(H2 O) HELIX 1 AA1 LYS A 28 TYR A 32 5 5 HELIX 2 AA2 GLU A 62 THR A 65 5 4 HELIX 3 AA3 ARG A 87 THR A 91 5 5 HELIX 4 AA4 SER A 138 LYS A 140 5 3 HELIX 5 AA5 SER A 167 ALA A 169 5 3 HELIX 6 AA6 SER A 198 THR A 202 5 5 HELIX 7 AA7 LYS A 212 ASN A 215 5 4 HELIX 8 AA8 GLN B 79 PHE B 83 5 5 HELIX 9 AA9 SER B 121 SER B 127 1 7 HELIX 10 AB1 LYS B 183 LYS B 188 1 6 HELIX 11 AB2 ASN C 32 THR C 34 5 3 HELIX 12 AB3 PRO C 60 SER C 64 5 5 HELIX 13 AB4 VAL C 70 GLY C 76 5 7 HELIX 14 AB5 ASP C 83 HIS C 90 1 8 SHEET 1 AA1 4 GLN A 3 GLN A 6 0 SHEET 2 AA1 4 VAL A 18 SER A 25 -1 O LYS A 23 N VAL A 5 SHEET 3 AA1 4 THR A 78 LEU A 83 -1 O LEU A 83 N VAL A 18 SHEET 4 AA1 4 VAL A 68 ASP A 73 -1 N THR A 71 O TYR A 80 SHEET 1 AA2 6 GLU A 10 LYS A 12 0 SHEET 2 AA2 6 THR A 118 VAL A 122 1 O THR A 121 N GLU A 10 SHEET 3 AA2 6 ALA A 92 GLU A 99 -1 N ALA A 92 O VAL A 120 SHEET 4 AA2 6 MET A 34 GLN A 39 -1 N VAL A 37 O TYR A 95 SHEET 5 AA2 6 LEU A 45 ILE A 51 -1 O MET A 48 N TRP A 36 SHEET 6 AA2 6 ILE A 58 TYR A 60 -1 O LYS A 59 N TYR A 50 SHEET 1 AA3 4 GLU A 10 LYS A 12 0 SHEET 2 AA3 4 THR A 118 VAL A 122 1 O THR A 121 N GLU A 10 SHEET 3 AA3 4 ALA A 92 GLU A 99 -1 N ALA A 92 O VAL A 120 SHEET 4 AA3 4 PHE A 111 TRP A 114 -1 O TYR A 113 N ARG A 98 SHEET 1 AA4 4 SER A 131 LEU A 135 0 SHEET 2 AA4 4 THR A 146 TYR A 156 -1 O LEU A 152 N PHE A 133 SHEET 3 AA4 4 TYR A 187 PRO A 196 -1 O TYR A 187 N TYR A 156 SHEET 4 AA4 4 VAL A 174 THR A 176 -1 N HIS A 175 O VAL A 192 SHEET 1 AA5 4 THR A 142 SER A 143 0 SHEET 2 AA5 4 THR A 146 TYR A 156 -1 O THR A 146 N SER A 143 SHEET 3 AA5 4 TYR A 187 PRO A 196 -1 O TYR A 187 N TYR A 156 SHEET 4 AA5 4 VAL A 180 LEU A 181 -1 N VAL A 180 O SER A 188 SHEET 1 AA6 3 THR A 162 TRP A 165 0 SHEET 2 AA6 3 ILE A 206 HIS A 211 -1 O ASN A 208 N SER A 164 SHEET 3 AA6 3 THR A 216 LYS A 221 -1 O VAL A 218 N VAL A 209 SHEET 1 AA7 4 MET B 4 SER B 7 0 SHEET 2 AA7 4 VAL B 19 ALA B 25 -1 O ARG B 24 N THR B 5 SHEET 3 AA7 4 ASP B 70 ILE B 75 -1 O TYR B 71 N CYS B 23 SHEET 4 AA7 4 PHE B 62 SER B 67 -1 N SER B 63 O THR B 74 SHEET 1 AA8 6 SER B 10 SER B 14 0 SHEET 2 AA8 6 THR B 102 LYS B 107 1 O GLU B 105 N LEU B 11 SHEET 3 AA8 6 ALA B 84 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA8 6 LEU B 33 GLN B 38 -1 N TYR B 36 O PHE B 87 SHEET 5 AA8 6 LYS B 45 TYR B 49 -1 O LEU B 47 N TRP B 35 SHEET 6 AA8 6 ARG B 53 LEU B 54 -1 O ARG B 53 N TYR B 49 SHEET 1 AA9 4 SER B 10 SER B 14 0 SHEET 2 AA9 4 THR B 102 LYS B 107 1 O GLU B 105 N LEU B 11 SHEET 3 AA9 4 ALA B 84 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA9 4 THR B 97 PHE B 98 -1 O THR B 97 N GLN B 90 SHEET 1 AB1 4 SER B 114 PHE B 118 0 SHEET 2 AB1 4 THR B 129 PHE B 139 -1 O LEU B 135 N PHE B 116 SHEET 3 AB1 4 TYR B 173 SER B 182 -1 O LEU B 175 N LEU B 136 SHEET 4 AB1 4 SER B 159 VAL B 163 -1 N GLN B 160 O THR B 178 SHEET 1 AB2 4 ALA B 153 LEU B 154 0 SHEET 2 AB2 4 LYS B 145 VAL B 150 -1 N VAL B 150 O ALA B 153 SHEET 3 AB2 4 VAL B 191 THR B 197 -1 O GLU B 195 N GLN B 147 SHEET 4 AB2 4 VAL B 205 ASN B 210 -1 O VAL B 205 N VAL B 196 SHEET 1 AB3 6 SER C 9 PHE C 12 0 SHEET 2 AB3 6 ARG C 103 TYR C 113 1 O LYS C 112 N VAL C 10 SHEET 3 AB3 6 GLY C 92 GLU C 100 -1 N GLY C 92 O LEU C 111 SHEET 4 AB3 6 VAL C 36 PHE C 42 -1 N LYS C 39 O GLU C 97 SHEET 5 AB3 6 ARG C 45 ASP C 51 -1 O TYR C 48 N TRP C 40 SHEET 6 AB3 6 LYS C 56 THR C 58 -1 O LYS C 56 N ASP C 51 SHEET 1 AB4 3 VAL C 19 ILE C 21 0 SHEET 2 AB4 3 LEU C 80 MET C 82 -1 O MET C 82 N VAL C 19 SHEET 3 AB4 3 LYS C 67 ILE C 68 -1 N LYS C 67 O LYS C 81 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.04 SSBOND 2 CYS A 151 CYS A 207 1555 1555 2.05 SSBOND 3 CYS B 23 CYS B 88 1555 1555 2.05 SSBOND 4 CYS B 134 CYS B 194 1555 1555 2.04 SSBOND 5 CYS C 23 CYS C 96 1555 1555 2.05 LINK ND2 ASN C 16 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN C 32 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN C 55 C1 NAG F 1 1555 1555 1.46 LINK ND2 ASN C 93 C1 NAG C 201 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O6 NAG D 1 C1 FUC D 3 1555 1555 1.45 LINK O6 NAG E 1 C1 FUC E 2 1555 1555 1.44 LINK O6 NAG F 1 C1 FUC F 2 1555 1555 1.44 CISPEP 1 PHE A 157 PRO A 158 0 -6.11 CISPEP 2 GLU A 159 PRO A 160 0 -4.23 CISPEP 3 SER B 7 PRO B 8 0 -1.75 CISPEP 4 PHE B 94 PRO B 95 0 -6.31 CISPEP 5 TYR B 140 PRO B 141 0 5.13 CRYST1 60.830 100.480 163.320 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016439 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009952 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006123 0.00000